Enhabit Inc. (NYSE: EHAB) is continuing to mull over a potential sale, with executives providing few details as the company determines its next steps. The Dallas-based home health and hospice company has been digging into a strategic review process since August that could result in a possible sale or merger of some or all of […]
Enhabit Inc. (NYSE: EHAB) must be put up for sale, according to a letter from minority investor AREX Capital Management to the home health and hospice company’s board. AREX owns about 4.7% of Enhabit’s shares. The hedge fund first posited that Enhabit should be sold in a June letter to the board. Enhabit in August […]
After becoming a public entity last year, Enhabit Inc.’s (NYSE: EHAB) M&A journey has narrowed towards hospice, diverting less in home health’s direction. Reimbursement uncertainties, shrinking pools of available assets, and rising valuations in the home health space are forces steering the company’s sights towards hospice, according to Enhabit executives. Large-scale consolidation in both home […]
Hospice of the Panhandle Promotes New CEO from Within West Virginia-based Hospice of the Panhandle has appointed Chief Clinical Officer Nikki Bigiarelli as its new CEO. Bigiarelli will work alongside its current CEO Margaret Cogswell before she retires on June 1, 2023. Cogswell has led the organization for the past 36 years. As Bigiarelli takes […]
Workforce improvement is at the crux of Enhabit, Inc.’s (NYSE: EHAB) hospice growth plans. Seeing recent clinical staffing gains, the company’s recruitment priorities include reinforcing its sales team to draw more referrals. Labor has been a big “swing factor” in Enhabit’s ability to sustain and grow its services, particularly on the hospice side, CEO Barbara […]
Gentiva’s recent $710 million acquisition of ProMedica’s hospice and home-based care assets bucks prevailing trends in today’s M&A market. Transaction volume dipped during 2022, specifically when it came to large platform deals by private equity firms. Many in the space expect smaller deals to become more prevalent during the first half of 2023, particularly in […]
Though investors and strategic buyers didn’t wade quite as deep into the hospice market in 2022 compared to years prior, the tide may be rising for M&A during 2023. Though hospice M&A activity fluctuated last year, volume is expected to rebound, but probably with larger numbers of smaller deals. Swelling demand for hospice and home […]
A new multi-state home health and hospice player, VitalCaring Group, has emerged under the leadership of health care entrepreneur and executive April Anthony. Most recently, Anthony was CEO of home health and hospice for Encompass Health (NYSE: EHC). She stepped down from that role in spring 2021. This came just months before Encompass began its […]
Mortality predictions and behavioral nudges by machine learning systems are associated with increased advance care planning utilization and reductions in high-acuity care. Researchers at the University of Pennsylvania recently studied the effectiveness of machine learning algorithms in identifying high-risk cancer patients nearing the last six months of life between June 17, 2019 and April 20, […]
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. Optum to pick up LHC Group Though […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
